Unresponsiveness to AmBisome in some Sudanese patients with kala-azar

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 1, 2007, Pages 19-24

  Mueller, Marius ^a   Ritmeijer, Koert ^a   Balasegaram, Manica ^a   Koummuki, Youssif ^a   Santana, Muriel Ramirez ^a   Davidson, Robert ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

AmBisome; Kala azar; Sudan; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; FERROUS SULFATE; FOLIC ACID; MULTIVITAMIN; RETINOL; STIBOGLUCONATE SODIUM; TUBERCULOSTATIC AGENT;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; ASPIRATION; CALORIC INTAKE; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALARIA; MALE; MONOTHERAPY; RELAPSE; SUDAN; SUPERINFECTION; TREATMENT OUTCOME; TUBERCULOSIS; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; LEISHMANIASIS, VISCERAL; MALE; RISK FACTORS; TREATMENT FAILURE; TUBERCULOSIS;

NASO HEXACANTHUS;

EID: 33750516526     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.02.005     Document Type: Article

References (13)

1. Adler-Moore J., and Proffitt R.T. AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. J. Antimicrob. Chemother. 49 Suppl. 1 (2002) 21-30
2. Berman J. Current treatment approaches to leishmaniasis. Curr. Opin. Infect. Dis. 16 (2003) 397-401
3. Berman J. Recent developments in leishmaniasis: epidemiology, diagnosis, and treatment. Curr. Infect. Dis. Rep. 7 (2005) 33-38
4. Berman J.D., Badaro R., Thakur C.P., Wasunna K.M., Behbehani K., Davidson R., Kuzoe F., Pang L., Weerasuriya K., and Bryceson A.D. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull. World Health Organ. 76 (1998) 25-32
5. Chulay J.D., and Bryceson A.D. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 32 (1983) 475-479
6. Davidson R.N., and Russo R. Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clin. Infect. Dis. 19 (1994) 560
7. Espuelas S., Legrand P., Loiseau P.M., Bories C., Barratt G., and Irache J.M. In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188. Antimicrob. Agents Chemother. 44 (2000) 2190-2192
8. Freire M., Badaro F., Avelar M.E., Luz K., Nakatani M.S., Teixeira R., Martins Netto E., and Badaro R. Efficacy and tolerability of liposomal amphotericin B (Ambisome) in the treatment of visceral leishmaniasis in Brazil. Braz. J. Infect. Dis. 1 (1997) 230-240
9. Montana M., Chochoi N., Monges P., Ravaux I., Faraut F., Gensollen S., Bongrand M.C., Timon-David P., and Gallais H. Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases. Pathol. Biol. 52 (2004) 66-75
10. National Malaria Schistosomiasis Leishmaniasis Administration (NMSLA), Sudan, 2004. Manual for the diagnosis and treatment of leishmaniasis. Republic of Sudan Federal Ministry of Health.
11. Russo R., Nigro L.C., Minniti S., Montineri A., Gradoni L., Caldeira L., and Davidson R.N. Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). J. Infect. 32 (1996) 133-137
12. Seaman J., Boer C., Wilkinson R., de Jong J., de Wilde E., Sondorp E., and Davidson R. Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clin. Infect. Dis. 21 (1995) 188-193
13. Thakur C.P., Pandey A.K., Sinha G.P., Roy S., Behbehani K., and Olliaro P. Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 319-322